[Urinary protein reduction by anticoagulant and fibrinolytic therap- in membranous glomerulonephropathy].
D000925:Anticoagulants / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D008875:Middle Aged
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D004176:Dipyridamole